Protalix BioTherapeutics Issues 2021 Letter to Stockholders

Protalix BioTherapeutics Issues 2021 Letter to Stockholders

Protalix BioTherapeutics, Inc. (NYSE American: PLX) (TASE: PLX), a biopharmaceutical company focused on the development, production

Check Also

Trump’s 10% tariff on UK products to come into force as stock markets plunge

Trump’s 10% tariff on UK products to come into force as stock markets plunge

The FTSE 100 fell on Friday in its worst day of trading since the start …

Barbarians at the gates

Barbarians at the gates

From black stars on European goods to apps showing what’s Canadian, consumers can respond to …

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.